Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2003
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037266A2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003022192B1 Eustachian tube stent
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002096432A3 Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002039953A9 Texaphyrin coordination compounds and uses thereof
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002026223A3 Catecholamine pharmaceutical compositions and methods
05/08/2003WO2002024226A9 Photosensitisers
05/08/2003WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/08/2003US20030088233 For use in ocular surgery; containing a vital dyes, especially a disazo dye, that does not diffuse out of the visco-elastic composition.
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030087957 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
05/08/2003US20030087949 For treating neurodegenerative diseases, diseases of circulatory organs, hepatitis, renal diseases, inflammatory skin disorders, radiation disorders, viral diseases, prion diseases, etc.; preservatives
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087910 E.g., O-(2-quinolinylmethyl)-N-quinaldoyl-D,L-tyrosine
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087893 Compositions containing alpha-2-adrenergic agonist components
05/08/2003US20030087889 Photodynamic therapy of occult age-related macular degeneration
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087875 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087807 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087246 Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086914 Method and device for inducing biological processes by micro-organs
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2466152A1 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003CA2465714A1 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003CA2464995A1 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464194A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003CA2464191A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308500A1 Ophthalmic composition
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/07/2003EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307185A2 Method for the prevention and treatment of retinopathy
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP0954281B1 Moistening preparation
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/06/2003USRE38115 Treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559166 A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6558688 Ocular tissue regeneration inducer
05/06/2003CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306093A1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
05/02/2003EP1306089A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics or calcium antagonists
05/02/2003EP1306088A1 Combination of a benzimidazole having angiotensin-II antagonistic activity with a diuretic
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 531